» Articles » PMID: 37095469

Transcriptome Profiling of a Synergistic Volumetric Muscle Loss Repair Strategy

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2023 Apr 24
PMID 37095469
Authors
Affiliations
Soon will be listed here.
Abstract

Volumetric muscle loss overwhelms skeletal muscle's ordinarily capable regenerative machinery, resulting in severe functional deficits that have defied clinical repair strategies. In this manuscript we pair the early in vivo functional response induced by differing volumetric muscle loss tissue engineering repair strategies that are broadly representative of those explored by the field (scaffold alone, cells alone, or scaffold + cells) to the transcriptomic response induced by each intervention. We demonstrate that an implant strategy comprising allogeneic decellularized skeletal muscle scaffolds seeded with autologous minced muscle cellular paste (scaffold + cells) mediates a pattern of increased expression for several genes known to play roles in axon guidance and peripheral neuroregeneration, as well as several other key genes related to inflammation, phagocytosis, and extracellular matrix regulation. The upregulation of several key genes in the presence of both implant components suggests a unique synergy between scaffolding and cells in the early period following intervention that is not seen when either scaffolds or cells are used in isolation; a finding that invites further exploration of the interactions that could have a positive impact on the treatment of volumetric muscle loss.

Citing Articles

Tissue Engineered 3D Constructs for Volumetric Muscle Loss.

Gahlawat S, Oruc D, Paul N, Ragheb M, Patel S, Fasasi O Ann Biomed Eng. 2024; 52(9):2325-2347.

PMID: 39085677 PMC: 11329418. DOI: 10.1007/s10439-024-03541-w.

References
1.
Cattin A, Burden J, Van Emmenis L, Mackenzie F, Hoving J, Garcia Calavia N . Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves. Cell. 2015; 162(5):1127-39. PMC: 4553238. DOI: 10.1016/j.cell.2015.07.021. View

2.
Yoshikawa M, Nakasa T, Ishikawa M, Adachi N, Ochi M . Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications. Bone Joint Res. 2017; 6(5):277-283. PMC: 5457645. DOI: 10.1302/2046-3758.65.BJR-2016-0187.R1. View

3.
Greising S, Corona B, McGann C, Frankum J, Warren G . Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis. Tissue Eng Part B Rev. 2019; 25(6):510-525. DOI: 10.1089/ten.TEB.2019.0207. View

4.
LHeureux N, Letourneur D . Clinical translation of tissue-engineered constructs for severe leg injuries. Ann Transl Med. 2015; 3(10):134. PMC: 4486912. DOI: 10.3978/j.issn.2305-5839.2015.05.03. View

5.
Urciuolo A, Urbani L, Perin S, Maghsoudlou P, Scottoni F, Gjinovci A . Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration. Sci Rep. 2018; 8(1):8398. PMC: 5976677. DOI: 10.1038/s41598-018-26371-y. View